Entering text into the input field will update the search result below
Create free account
Search for Symbols, analysts, keywords
Log in
Analysis
All Analysis
Basic Materials
Biotech
Bonds
Closed End Funds
Commodities
Communication Services
Consumer
Consumer Staples
Cryptocurrency
Dividend Ideas
Dividend Quick Picks
Dividend Strategy
Dividends
Economy
Editors' Picks
Energy
ETF Analysis
ETFs and Funds
Financial Advisor
Financials
Fixed Income
Forex
Gold & Precious Metals
Growth
Healthcare
Industrial
Investing Strategy
IPOs
Long Ideas
Market Outlook
Micro-Caps
Mutual Funds
Portfolio Strategy
Quick Picks & Lists
Real Estate
REITs
Retirement
Small-Caps
Stock Ideas
Tech
Utilities
Value
Long And Short Stock Ideas
Fate Therapeutics: Looking For A Potential Turnaround In 2024
Safran Stock: An Aerospace Powerhouse To Buy
Nvidia's Reversion Angle Became Steeper
Snap: Massive Upside Looks Possible (Technical Analysis)
Visa: The Payment 'Toll Booth' Outperforms Again - Maintain Buy
A Focus On Free Cash Flow Sets CNX Resources Apart In The Energy Sector
Skeena Resources: Robust Prospects With Potentially More Attractive Stock Price
Saia: Recent Correction Is A Buying Opportunity
Forestar Group Stock To Benefit From The Real Estate Shortage
Shopify: Inflection Point Likely Arrived As Fears Peaked (Rating Upgrade)
AT&T: Keep Buying As Long As The Market Keeps Ignoring
Frontier Group Holdings: Growth Fueled By Surge In Passengers And Strategic Promotions
Rightmove: This Could Be The Right Time To Buy Shares
Cellebrite: Big Fish In A Small Pond
Rigel Pharmaceuticals: No Respect With Little Justification, Worth Considering A Buy
4D Molecular Therapeutics: Catalysts With Pioneering Gene Therapy With Directed Evolution
Unveiling AbbVie's Winning Strategy In Pharmaceutical Innovation (Rating Upgrade)
Shopify Direct Sales Should Win As Amazon Shifts Toward 'Pay To Play' Model
Citigroup: The Catalyst That Could Trigger A Melt-Up
AFYA: Mr Market Is Mistaken
Marsh & McLennan: Scale Advantage And Macro Uncertainty Support Growth Story
Textron: A Post-Earnings Plunge Is My Buying Opportunity
Loar Holdings: This Aerospace Supplier Is Flying Too High In Its IPO
Danaos: The Valuation Math Still Heavily Favors Bulls
PayPal Q1 Preview: Major Changes, Major Quarter (Rating Upgrade)
Artisan Value Income Fund Q1 2024 Commentary
Artisan International Explorer Fund Q1 2024 Commentary
Reddit: Buy The Post-IPO Dip
Fortive Corporation: Attractively Valued With Good Growth Prospects
ClearBridge Global Value Improvers Strategy Q1 2024 Commentary
ClearBridge SMID Cap Growth Strategy Q1 2024 Commentary
Greenhaven Road Partners Fund Q4 2023 Letter
A.P. Møller Maersk A/S ADR Investors Face Calm Seas Ahead
M/I Homes: Strong Foundations Will Allow It To Continue Growing
Churchill Downs: Making A Wager On This Proven Compounder
Greenhaven Road Capital Main Fund Q1 2024 Investor Letter
Exxon Mobil Needs Consistent Perfect Execution
Roche: Value Remains Despite Covid-19 Revenue Growth Loss
3 'Buy-Rated' Biotech Stocks Under $10
Rubrik: A Strong IPO In A Tough Market
1
2
3
4
5
Next